| Pubmed ID |
Author | Year | Title |
19704410 |
Svendsen PF | 2009 | Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome. |
19706563 |
Nur MM | 2009 | Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome. |
19708174 |
Begum MR | 2009 | Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. |
19711741 |
Meczekalski B | 2009 | [The role of inhibins in functions and dysfunctions of female reproduction--Part II]. |
19713424 |
Tosi F | 2009 | Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome. |
19714502 |
Crisosto N | 2009 | Testosterone-induced downregulation of anti-M?llerian hormone expression in granulosa cells from small bovine follicles. |
19718565 |
Liu X | 2010 | Genetic variants of cyclin-dependent kinase 5 regulatory subunit associated protein 1-like 1 and transcription factor 7-like 2 are not associated with polycystic ovary syndrome in Chinese women. |
19718569 |
Cetinkalp S | 2010 | The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients. |
19718570 |
Unluhizarci K | 2010 | The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. |
19718584 |
Alshammari A | 2010 | Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes? |
19720270 |
Benjamins LJ | 2009 | Evaluation and management of polycystic ovary syndrome. |
19721481 |
Carlsen SM | 2009 | [Use of metformin in polycystic ovary syndrome]. |
19723303 |
Mohamed-Hussein ZA | 2009 | Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data. |
19726039 |
Pall M | 2010 | The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. |
19729161 |
Ashrafinia M | 2009 | Comparison of metformin treatment and laparoscopic ovarian diathermy in patients with polycystic ovary syndrome. |
19729414 |
Bausenwein J | 2010 | Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women. |
19729797 |
Samy N | 2009 | Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. |
19732872 |
Farhi J | 2010 | Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome. |
19732886 |
Gu BH | 2009 | Follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome. |
19732888 |
Abu Hashim H | 2010 | Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. |
19733099 |
Shah B | 2010 | Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. |
19734445 |
Fauser BC | 2009 | Predicting pregnancy in women with polycystic ovary syndrome. |
19735349 |
Jeanes YM | 2009 | Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians. |
19740916 |
Gowri V | 2009 | Investigating infertility. |
19744034 |
Erdogan M | 2009 | The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients. |
19749195 |
James WH | 2009 | A new method for testing a hypothesis on a cause of polycystic ovary syndrome. |
19749677 |
De Leo V | 2009 | [Low dose oral contraceptives: 30 microg are still used?]. |
19754381 |
Motta AB | 2009 | Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome. |
19757237 |
Duijkers IJ | 2010 | Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. |
19757275 |
Qublan HS | 2009 | Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial. |
19761360 |
Overbeek A | 2009 | Pharmacogenomics of ovulation induction: facilitating decisions on who, when and how to treat. |
19763092 |
Oh JY | 2010 | Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome. |
19765700 |
Rocha MP | 2010 | Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome. |
19766209 |
Hu Z | 2010 | The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome. |
19771438 |
Verit FF | 2010 | High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome. |
19775306 |
Seneviratne HR | 2009 | Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome. |
19778476 |
Dittrich R | 2009 | Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. |
19778486 |
Chittenden BG | 2009 | Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. |
19781047 |
Zhang HY | 2009 | Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. |
19781696 |
Harris-Glocker M | 2010 | Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. |
19782347 |
Verit FF | 2009 | Serologic markers of autoimmunity in women with the polycystic ovary syndrome. |
19782351 |
Wang Y | 2010 | Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant. |
19782356 |
Kaya C | 2010 | Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome. |
19782423 |
Kawai T | 2009 | Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome. |
19782978 |
Ozerkan K | 2010 | Insulin-like growth factor-1 and insulin-like growth factor-binding protein-1 in patients with polycystic ovary syndrome during clomiphene citrate therapy. |
19794294 |
Meczekalski B | 2009 | Oocyte-specific genes: role in fertility and infertility. |
19796964 |
de Zegher F | 2009 | Adipose tissue expandability and the early origins of PCOS. |
19800728 |
Papaleo E | 2009 | Contribution of myo-inositol to reproduction. |
19803824 |
Wiegratz I | 2006 | Extended and continuous use of hormonal contraceptives to reduce menstruation. |
19803867 |
Lim SS | 2007 | Obesity management in women with polycystic ovary syndrome. |
19803884 |
Unluhizarci K | 2005 | The evaluation and treatment of hirsute women. |
19803963 |
Diamanti-Kandarakis E | 2006 | Update on polycystic ovary syndrome. |
19803983 |
Szalat A | 2007 | Gender-specific care of diabetes. |
19803994 |
Yasmin E | 2007 | Management of polycystic ovary syndrome. |
19804008 |
Seng SW | 2006 | Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation. |
19804310 |
Rizzo M | 2007 | Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. |
19805079 |
Mutskov V | 2009 | The human insulin gene is part of a large open chromatin domain specific for human islets. |
19808859 |
de Zegher F | 2009 | Early Origins of polycystic ovary syndrome: hypotheses may change without notice. |
19809318 |
Palomba S | 2009 | Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance. |
19809879 |
Ode KL | 2009 | Identification and treatment of metabolic complications in pediatric obesity. |
19811070 |
Atiomo WU | 2009 | Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. |
19811236 |
Carmina E | 2009 | Cardiovascular risk and events in polycystic ovary syndrome. |
19815190 |
Gosman GG | 2010 | Reproductive health of women electing bariatric surgery. |
19818376 |
Racho? D | 2010 | Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. |
19820292 |
Misiti S | 2010 | Proteomic profiles in hyperandrogenic syndromes. |
19820295 |
Selimoglu H | 2010 | The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. |
19821101 |
Chu Y | 2009 | The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance. |
19821295 |
Brown J | 2009 | Clomiphene and anti-oestrogens for ovulation induction in PCOS. |
19821299 |
Tang T | 2009 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. |
19827418 |
Klein F | 2009 | [Polycystic ovary syndrome. Diet helps control hormone chaos]. |
19827632 |
Reznikov OH | 2009 | [Enhancing effect of androgen receptor antagonist on gonadotropic inductors of ovulation in rats with polycystic ovaries]. |
19828691 |
Zhu JQ | 2010 | Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. |
19832825 |
Dewailly D | 2010 | Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level. |
19832931 |
Caruso S | 2009 | Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. |
19834313 |
Moran LJ | 2010 | Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. |
19835809 |
Fambrini M | 2009 | Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report. |
19837913 |
Coviello AD | 2009 | High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. |
19837928 |
Jones MR | 2009 | Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. |
19838579 |
Fernandes JB | 2009 | [Obesity and altered arterial structure in young women with micropolycystic ovary syndrome]. |
19841045 |
Diamanti-Kandarakis E | 2010 | Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. |
19843067 |
Nakhjavani M | 2009 | Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism. |
19843375 |
Oyawoye OA | 2009 | The interaction between follicular fluid total antioxidant capacity, infertility and early reproductive outcomes during in vitro fertilization. |
19844814 |
Wang J | 2009 | FABP4: a novel candidate gene for polycystic ovary syndrome. |
19845194 |
Awonuga AO | 2009 | Non-adherence to instructions to cancel a cycle in a patient overstimulated with gonadotropins in a planned intrauterine insemination cycle. |
19845195 |
Chervenak FA | 2009 | Preventive ethics and subsequent care of patients self-administering ovarian stimulation for the management of infertility. |
19846740 |
Alsamarai S | 2009 | Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. |
19848208 |
Li Q | 2009 | [Effect of bushen tongmai recipe on insulin resistance and ovulation dysfunction in PCOS rats accompanied with insulin resistance]. |
19850592 |
Rosencrantz MA | 2010 | Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women. |
19852285 |
Yu J | 2009 | [Fifty years of experience on integrative medical treatment of polycystic ovarian syndrome]. |
19852286 |
Huang HF | 2009 | [Genetic mechanism of polycystic ovarian syndrome]. |
19852287 |
Wu XK | 2009 | [Exploration into the pathogenesis and treatment of polycystic ovarian syndrome from viewpoints of menstrual disorder and phlegm accumulation in uterus]. |
19852289 |
Zhao H | 2009 | [Advantages of Chinese medicine for treatment of blood sugar and lipid metabolic disorders in patients with polycystic ovarian syndrome]. |
19852296 |
Gao L | 2009 | [Of berberine and puerarin on dexamethasone-induced insulin resistance in porcine ovarian thecal cells]. |
19855107 |
Lujan ME | 2010 | Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. |
19856137 |
Lin S | 2009 | The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome. |
19859840 |
Yan Q | 2009 | Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women. |
19860350 |
Check JH | 2009 | Failure to have menses following progesterone withdrawal in a normal estrogenic woman with polycystic ovarian syndrome who menstruates with oral contraceptives. |
19874358 |
Ingram JR | 2010 | Management of acne vulgaris: an evidence-based update. |
19883437 |
Yamada S | 2009 | Stromal luteoma and nodular hyperthecosis of the bilateral ovaries associated with atypical endometrial hyperplasia of the uterus. |
19883744 |
Manner?s L | 2010 | Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome. |
Showing 8,501–8,600 of 14,368